These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27439631)

  • 1. Evaluation of malnutrition as a predictor of adverse outcomes in febrile neutropenia associated with paediatric haematological malignancies.
    Chaudhuri J; Biswas T; Datta J; Sabui TK; Chatterjee S; Ray S; Raychaudhuri D; Mandal K; Chatterjee K; Chakraborty S
    J Paediatr Child Health; 2016 Jul; 52(7):704-9. PubMed ID: 27439631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
    Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive fungal infection in children with persistent febrile neutropenia.
    Lai HP; Chen YC; Chang LY; Lu CY; Lee CY; Lin KH; Huang LM
    J Formos Med Assoc; 2005 Mar; 104(3):174-9. PubMed ID: 15818431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of micafungin for febrile neutropenia in pediatric patients with hematological malignancies: a multicenter prospective study.
    Kobayashi R; Suzuki N; Yoshida M; Iizuka S; Suzuki D; Sano H; Kudoh T
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):e276-9. PubMed ID: 23743960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria parasitemia associated with febrile neutropenia in African patients undergoing chemotherapy for haematological malignancies. A report of three patients.
    Rapoport BL; Uys A
    Chemotherapy; 2008; 54(2):117-9. PubMed ID: 18303260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropenia.
    Butts AR; Bachmeier CC; Dressler EV; Liu M; Cowden A; Talbert J; Adams VR
    J Oncol Pharm Pract; 2017 Jun; 23(4):278-283. PubMed ID: 28077045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi.
    Israëls T; van de Wetering MD; Hesseling P; van Geloven N; Caron HN; Molyneux EM
    Pediatr Blood Cancer; 2009 Jul; 53(1):47-52. PubMed ID: 19338050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
    Baskaran ND; Gan GG; Adeeba K
    Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive model for the length of hospital stay of children with hematologic malignancies, neutropenia, and presumed infection.
    Pastura PS; Land MG; Santoro-Lopes G
    J Pediatr Hematol Oncol; 2004 Dec; 26(12):813-6. PubMed ID: 15591901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
    Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP
    J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcome of febrile neutropenic episodes in paediatric oncology at the Wendy Fitzwilliam Paediatric Hospital.
    Timothy M; Bodkyn C
    West Indian Med J; 2011 Mar; 60(2):153-7. PubMed ID: 21942119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy.
    Nakagawa Y; Suzuki K; Masaoka T
    J Infect Chemother; 2009 Jun; 15(3):174-9. PubMed ID: 19554402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mold colonization of fiberglass insulation of the air distribution system: effects on patients with hematological malignancies.
    Takuma T; Okada K; Yamagata A; Shimono N; Niki Y
    Med Mycol; 2011 Feb; 49(2):150-6. PubMed ID: 20807030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy.
    Juutilainen A; Vänskä M; Pulkki K; Hämäläinen S; Nousiainen T; Jantunen E; Koivula I
    Eur J Haematol; 2011 Nov; 87(5):441-7. PubMed ID: 21676033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
    Karaman S; Vural S; Yildirmak Y; Emecen M; Erdem E; Kebudi R
    Pediatr Blood Cancer; 2012 Apr; 58(4):579-83. PubMed ID: 21674768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefepime monotherapy for treatment of febrile neutropenia in children.
    Ariffin H; Ai CL; Lee CL; Abdullah WA
    J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematological malignancy in the intensive care unit: microbiology results and mortality.
    van Beers EJ; Müller MC; Vlaar AP; Spanjaard L; van den Bergh WM;
    Eur J Haematol; 2016 Sep; 97(3):271-7. PubMed ID: 26676382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
    Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.